These data suggest that IL-27 may be exploited to restore HLA class I expression in SCLC cells without inducing a strong PD-L1-mediated adaptive immune resistance, which is a hallmark of IFN-γ [15]. Here, IL27 is linked to small cell lung carcinoma.